EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps

Vytautas Kiudelis, Juozas Kupcinskas, Alexander Link

Best Practice & Research Clinical Gastroenterology · 2025

DOI: 10.1016/j.bpg.2025.102064 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Vytautas Kiudelis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Digestive Research and Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania. Hauptthemen laut MEDLINE: Feces, Inflammatory Bowel Diseases, MicroRNAs, Circulating MicroRNA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Forschung, Technologie und Raumfahrt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite substantial progress in understanding the complex pathophysiology of inflammatory bowel diseases (IBD), specific and accurate non-invasive biomarkers for diagnosis and disease monitoring remain an unmet clinical need. Endoscopy and histology are still considered the diagnostic gold standard, while fecal calprotectin has been increasingly adopted in practice but with recognized limitations. Blood-derived biomarkers, in contrast, remain largely nonspecific and of limited utility. Since the discovery of small non-coding RNAs known as microRNAs, these molecules have emerged as promising candidates for non-invasive diagnosis across a range of diseases, including IBD. Over the past decade, a growing body of research has investigated their potential in blood and fecal samples; however, systematic evaluation and integration of this evidence are still lacking. In this review, we provide a comprehensive synthesis of current studies on circulating and fecal miRNAs as non-invasive biomarkers for IBD, highlighting methodological heterogeneity and outlining key directions for future research toward clinically applicable next-generation biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesInflammatory Bowel DiseasesMicroRNAsCirculating MicroRNAHumansBiomarkersLeukocyte L1 Antigen Complex

Stichwörter der Autor:innen

BiomarkersBloodCrohn's diseaseFecesInflammatory bowel diseaseMicroRNAUlcerative colitisncRNA

Substanzen

BiomarkersMicroRNAsCirculating MicroRNALeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Institute for Digestive Research and Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Gastroenterology, Friedrich-Alexander University Erlangen-Nuernberg (FAU), Medical Campus Upper Franconia, Klinikum Bayreuth GmbH, Bayreuth, Germany. Electronic address: alexander.link@fau.de.

Förderung

  • Bundesministerium für Forschung, Technologie und Raumfahrt

Zitieren

APA

Kiudelis, V., Kupcinskas, J., & Link, A. (2025). Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.102064

Vancouver

Kiudelis V, Kupcinskas J, Link A. Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.102064

BibTeX
@article{Kiudelis2025,
  author = {Kiudelis, Vytautas and Kupcinskas, Juozas and Link, Alexander},
  title = {Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2025},
  doi = {10.1016/j.bpg.2025.102064}
}
Kostenlos starten →